We are live on ! Find out more
NRSN icon

NeuroSense Therapeutics
NRSN

13 hedge funds and large institutions have $287K invested in NeuroSense Therapeutics in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$44.6K
2
+$25.6K
3
+$18.9K
4
UBS Group
UBS Group
Switzerland
+$16.3K

Top Sellers

1
-$27.5K
2
-$19.6K
3
-$13.8K
4
Two Sigma Investments
Two Sigma Investments
New York
-$6.34K
5
SS
SBI Securities
Japan
-$1.06K
Name Holding Trade Value Shares
Change 		Change in
Stake
YAG
1
Yorkville Advisors Global
New Jersey
$58.9K
IAA
2
Independent Advisor Alliance
North Carolina
$37.8K
UBS Group
3
UBS Group
Switzerland
$37.1K
Two Sigma Investments
4
Two Sigma Investments
New York
$33.6K
MIH
5
Meitav Investment House
Israel
$30.2K
Jane Street
6
Jane Street
New York
$21.6K
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$17.2K
PNC Financial Services Group
8
PNC Financial Services Group
Pennsylvania
$16K
Pathstone Holdings
9
Pathstone Holdings
New Jersey
$12.5K
Geode Capital Management
10
Geode Capital Management
Massachusetts
$12K
Creative Planning
11
Creative Planning
Kansas
$8.99K
Jones Financial Companies
12
Jones Financial Companies
Missouri
$731
SS
13
SBI Securities
Japan
$200
GS
14
GTS Securities
New York
–
Squarepoint
15
Squarepoint
New York
–
JWM
16
Jessup Wealth Management
Ohio
–